April 17, 2017
The next meeting of the National Drug Scheduling Advisory Committee (NDSAC) is scheduled for Sunday, June 11, 2017. The primary purpose of the meeting is to consider the following matter:
- Request for Unscheduled status for minoxidil, when sold in preparations for topical use in concentrations of 5% or less, for human use only
Individuals, companies or organizations seeking Interested Party status for this agenda item are invited to contact NAPRA as soon as possible. All requests for Interested Party status must be submitted in writing to the NDSAC Secretariat via regular mail or E-mail no later than 4:00 p.m. (EST) on Thursday, April 27, 2017.
Alternate Method of Participation
Individuals, companies or organizations who chose not to pursue Interested Party status or have been denied the status, can provide comments, in writing, related to the agenda item outlined above. The comments must be received by the NDSAC Secretariat via regular mail or E-mail no later than 4:00 p.m. (EST) on Friday, June 2, 2017. Please note: only an acknowledgement of receipt for the comments received will be provided. All comments or information provided by this alternate method of participation shall be provided to NAPRA and any person, association or other entity that has realized Interested Party status.
For more information, please contact Sarah Jennings, Acting Manager, Professional and Regulatory Affairs, NAPRA at 613-569-9658, ext. 230 or via email at firstname.lastname@example.org .